SK3 Group Announces New Dedicated Investor Relation Contacts, Comments on AEGY Distribution

medicalgreenslogoMIAMI, FL–(Marketwired – Aug 26, 2013) – SK3 Group, Inc. (PINKSHEETS: SKTO) announces that its Investor relations consultant, Rubicon Capital Advisors has completed a dedicated web, phone and email presence for SKTO shareholder information. The new telephone # is 855-868-7577 (Dial 1 for direct IR)

“Having a dedicated team addressing all our shareholder inquiries will assist in allowing our team execute on the day-to-day value actions, however we will be in close contact on all matters related to investor and shareholder relations. We would ask at this time that shareholders only use this telephone number and email, again allowing our team to concentrate on bringing value to our core business,” comments Mr. A Mayor, President, SK3 Group.

Additionally, SK3 is still preparing for the distribution of the stock held in Alternative Energy Partners, which is expected be completed very soon. As was previously announced, this distribution of stock to the shareholders required that the shares be registered with the SEC before the distribution, a process which AEGY has agreed to undertake. This registration is a complex, expensive and time-consuming process and requires the completion of SEC review after filing, and the clearance of a Notice of Corporate Action filed with FINRA before it is effective. We are advised that AEGY will have the registration statement filed shortly, although an audit of its financial statements for its fiscal year ended July 31, 2013, must be completed before filing. Frequent updates will be made available as to the audit completion and effectiveness of the S1 in real time as The Company receives the latest information.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Contact:
Investor Relations Contact
joanne@rubiconcapitaladvisors.com
TEL: 855-868-7577 ( Dial 1 for direct IR)
www.rubiconcapitaladvisors.com

Tags: , , , , , ,